These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31675485)

  • 1. Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    FASEB J; 2019 Dec; 33(12):14394-14409. PubMed ID: 31675485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of osteoclast formation and bone resorption by glucocorticoids: Synergistic interactions with the calcium regulating hormones parathyroid hormone and 1,25(OH)
    Henning P; Conaway HH; Lerner UH
    Vitam Horm; 2022; 120():231-270. PubMed ID: 35953112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
    Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
    J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
    Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K
    J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones.
    Conaway HH; Grigorie D; Lerner UH
    J Endocrinol; 1997 Dec; 155(3):513-21. PubMed ID: 9487996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.
    Choudhary S; Goetjen A; Estus T; Jacome-Galarza CE; Aguila HL; Lorenzo J; Pilbeam C
    J Biol Chem; 2016 Feb; 291(8):3882-94. PubMed ID: 26703472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.
    Takuma A; Kaneda T; Sato T; Ninomiya S; Kumegawa M; Hakeda Y
    J Biol Chem; 2003 Nov; 278(45):44667-74. PubMed ID: 12944401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.
    Kuriwaka-Kido R; Kido S; Miyatani Y; Ito Y; Kondo T; Omatsu T; Dong B; Endo I; Miyamoto K; Matsumoto T
    Endocrinology; 2013 Mar; 154(3):1156-67. PubMed ID: 23397032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
    Onal M; St John HC; Danielson AL; Pike JW
    J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameloblastin and enamelin prevent osteoclast formation by suppressing RANKL expression via MAPK signaling pathway.
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Morikawa K; Saeki K; Maki K; Nishihara T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):621-626. PubMed ID: 28161637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
    Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.
    Kim S; Yamazaki M; Zella LA; Shevde NK; Pike JW
    Mol Cell Biol; 2006 Sep; 26(17):6469-86. PubMed ID: 16914732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.
    Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T
    Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.